Subscribe To
New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023
Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) — Opus Genetics, a patient-focu...
November 3, 2023, 7:43 pm
Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et
ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specia...
November 3, 2023, 12:41 pm
rare earth metals producer mp materials posts net loss in q3 on lower commodity prices
(Kitco News) - On Thursday, rare earth metals producer MP Materials (NYSE: MP) announced that in Q3 202...
November 3, 2023, 12:04 pm
Quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et
ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage special...
November 3, 2023, 8:41 am
Acadia pharmaceuticals inc. (acad) q3 2023 earnings call transcript
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Jessica Tieszen - Associa...
November 3, 2023, 3:54 am
Ultragenyx pharmaceutical, inc. (rare) q3 2023 earnings call transcript
Ultragenyx Pharmaceutical, Inc. (NASDAQ:rare ) Q3 2023 Earnings Conference Call November 2, 2023 5:00 P...
November 2, 2023, 10:29 pm
The north america rare disease summit focused on the need for centralized data to improve the lives of 30 million people living with rare conditions
Stakeholders debate at the North America rare Disease Summit on the challenges regarding treatment appr...
November 2, 2023, 7:51 pm
Genfit to present update on scientific and corporate progress at the liver meeting® 2023
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 2 2023 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage bio...
November 2, 2023, 5:10 pm
Initial jobless claims are coming up next
US dollar weakness is continuing today as there is a FOMO move in bonds with yields down 2-12 bps across the curve.Up next is the weekly initial joble...
November 2, 2023, 12:25 pm
Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition
– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease...
November 2, 2023, 9:05 am
Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 ctos annual meeting
– Nirogacestat Treatment Demonstrated Rapid and Sustained Improvements in Functional Status Compared to Placebo Across Multiple Assessment Tools –...
November 1, 2023, 10:30 am
Cardiol therapeutics reaches new milestone in phase ii study for recurrent pericarditis
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) announced it has successfully enrolled over 50% of the targeted number of patients for its Phase II open-...
November 1, 2023, 8:41 am
Astrazeneca inks gene editing deal that could end up costing it $2.5bn
AstraZeneca PLC (LSE:AZN) has entered into a partnership and investment deal with French gene editing specialist biotech firm Cellectis (NASDAQ:CLLS) ...
November 1, 2023, 3:59 am
Astrazeneca signs drug development deal with biotech cellectis
AstraZeneca said on Wednesday it had entered into a collaboration and investment agreement with clinical-stage biotechnology company Cellectis to spee...
November 1, 2023, 3:17 am
Energy fuels: not far from becoming a force to be reckoned with
Energy Fuels is well positioned to benefit from the growth of nuclear power and the increasing demand for uranium. The company has long-term contracts...
October 31, 2023, 9:54 pm
International equities are beating u.s. stocks in ‘rare’ outperformance. should you lighten up on non-u.s. equities?
U.S. stocks are lagging international equities over the past year, in an unusual occurrence, according to DataTrek Research. Read Full Story at source...
October 31, 2023, 7:29 pm
Filament health's expertise positions it to tap into multi-billion psychedelics opportunity
Analysts at Water Tower Research have initiated coverage on Filament Health Corp (OTCQB:FLHLF, NEO:FH) with a positive outlook on the firm which they ...
October 31, 2023, 3:44 pm
Amicus therapeutics: the right play now
Amicus Therapeutics, Inc. is a commercial-stage biotech company focused on developing therapies for rare...
October 31, 2023, 12:24 pm
Fulcrum therapeutics to host third quarter 2023 financial results conference call and webcast on tuesday, november 7, 2023, at 8:00 a.m. et
CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutica...
October 31, 2023, 8:50 am
Zevra therapeutics to report third quarter 2023 results on november 7, 2023, at 8:00 a.m. et
CELEBRATION, Fla., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company) a ...
October 31, 2023, 7:30 am